Coronary Stent Market Assessment
A Survey of Fifty Interventional Cardiologists
Panel Intelligence, LLC
February, 2009
Deliverable: Survey with key findings
STUDY DESCRIPTION
|
Topic |
The bare metal and drug-eluting stent market |
|
Respondent Type |
Physicians |
|
Specialties Covered |
Interventional Cardiologists |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website Duration: 20 minutes Size: 50 respondents Fielding Dates: February 4, 2009 to February 9, 2009 |
OBJECTIVES
To understand trends in coronary stent use among a group of fifty interventional cardiologists
§ Determine current levels of use for bare-metal and drug-eluting stents (DES)
§ Gauge the perceptions of stents from various manufacturers
§ Examine what determines physicians’ selection of a particular stent brand
§ Capture anticipated future product mix of the coronary stent market
Companies and Products Mentioned in This Report
|
Company |
Ticker Symbol |
Product(s) |
|
Abbott Laboratories |
ABT |
Vision, XIENCE V Everolimus Eluting Coronary Stent System |
|
B. Braun Medical Inc. |
private |
Coroflex® and Coroflex® Blue, Coroflex® Please |
|
Biosensors International Group, Ltd. |
BSNRF |
S-Stent™ |
|
Boston Scientific Corp. |
BSX |
Express2™, PROMUS® Everolimus-Eluting Coronary Stent System, TAXUS® (multiple models) |
|
Cordis |
JNJ |
CYPHER® Sirolimus-eluting Coronary Stent |
|
CorNova |
private |
Valecor Platinum™ |
|
MedLogics |
private |
COBRA™ |
|
Medtronic |
MDT |
Driver®, Endeavor® Drug-Eluting Coronary Stent |
|
Minnow Medical |
private |
No specific product mentioned |
|
MIV Therapeutics Inc. |
MIVI |
VESTAsync™ |
|
Reva Technology |
private |
Bioresorbable Coronary Stent |
|
Terumo Corp. |
TRUMF |
Nobori® |
|
XTENT® Inc |
XTNT |
Custom NX® DES Systems |
Inclusion Criteria and Respondent Demographics
|
Inclusion Criteria |
§ US-based interventional cardiologists § Board-certified in specialty § 2 to 30 years of experience post-residency § Minimum of 75% professional time spent in clinical practice § Place at least 15 stent implants per month |
Print Abstract
For additional information on this study or to purchase, please call:
|
Survey
Cardiology |